Oral administration of Gastrin‐SiO2 microspheres in these mice improved blood glucose control and decreased insulin resistance and obesity (the main hallmarks of T2D) in the HFD‐fed C57BL/6J mice. This evidence concerns the gene GAST and type 2 diabetes mellitus.